Upstream Bio, Stock Investor Sentiment

UPB Stock   16.44  0.68  3.97%   
About 56% of all Upstream Bio,'s investors are looking to take a long position. The analysis of overall sentiment of trading Upstream Bio, stock suggests that some investors are interested at this time. The current market sentiment, together with Upstream Bio,'s historical and current headlines, can help investors time the market. In addition, many technical investors use Upstream Bio, stock news signals to limit their universe of possible portfolio assets.
  
over a month ago at benzinga.com         
This Eaton Analyst Begins Coverage On A Bullish Note Here Are Top 5 Initiations For Tuesday
benzinga news
over a month ago at finance.yahoo.com         
Fannie Mae Announces the Results of its Thirty-third Reperforming Loan Sale Transaction
Yahoo News
over two months ago at finance.yahoo.com         
Fannie Mae Announces Winner of Twenty-Fifth Community Impact Pool of Non-Performing Loans
Yahoo News
over two months ago at finance.yahoo.com         
Mr. Cooper Group Reports Third Quarter 2024 Results
Yahoo News
over two months ago at finance.yahoo.com         
PennyMac Financial Services, Inc. Reports Third Quarter 2024 Results
Yahoo News
over two months ago at investing.com         
Upstream bio director Erez Chimovits buys 14 million in shares
Investing News at Macroaxis
over two months ago at investing.com         
OrbiMed Advisors LLC purchases 14 million in Upstream Bio shares
Investing News at Macroaxis
over two months ago at thelincolnianonline.com         
Upstream Bio, Inc. Major Shareholder Ai Upstream Llc Buys 1,175,000 Shares
news
over two months ago at globenewswire.com         
Upstream Bio Announces Closing of 293 Million Upsized Initial Public Offering,Including Full Exercis...
Macroaxis News: globenewswire.com
over two months ago at finance.yahoo.com         
Upstream Bio Announces Closing of 293 Million Upsized Initial Public Offering,Including Full Exercis...
Yahoo News
over two months ago at news.google.com         
Upstream Bio shares soar in impressive IPO - The Pharma Letter
Google News at Macroaxis
over two months ago at bizjournals.com         
Shares of two Mass. biotechs rise after IPOs
bizjournals News
over two months ago at seekingalpha.com         
Upstream Bio stock rallies 32 percent following upsized 255M IPO
seekingalpha News
over two months ago at finance.yahoo.com         
Fannie Mae Announces Winner of its Latest Non-Performing Loan Sale
Yahoo News
Far too much social signal, news, headlines, and media speculation about Upstream Bio, that are available to investors today. That information is available publicly through Upstream media outlets and privately through word of mouth or via Upstream internal channels. However, regardless of the origin, that massive amount of Upstream data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Upstream Bio, news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Upstream Bio, relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Upstream Bio,'s headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Upstream Bio, alpha.

Upstream Bio, Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Upstream Bio shares soar in impressive IPO - The Pharma Letter
10/14/2024
2
Upstream bio director Erez Chimovits buys 14 million in shares
10/17/2024
3
This Eaton Analyst Begins Coverage On A Bullish Note Here Are Top 5 Initiations For Tuesday
11/05/2024
4
Upstream Bio Advances Clinical Trials, Strengthens Financials - TipRanks
11/08/2024
5
Upstream Bio Inc Joins Russell 2000 Index
12/16/2024
6
Upstream Bio Appoints Allison Ambrose as General Counsel
12/17/2024

Complementary Tools for Upstream Stock analysis

When running Upstream Bio,'s price analysis, check to measure Upstream Bio,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Upstream Bio, is operating at the current time. Most of Upstream Bio,'s value examination focuses on studying past and present price action to predict the probability of Upstream Bio,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Upstream Bio,'s price. Additionally, you may evaluate how the addition of Upstream Bio, to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Bonds Directory
Find actively traded corporate debentures issued by US companies
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing